Abstract
Cisplatin is a metal coordination compound that was approved for clinical use in treating testicular cancer 5 years ago. Although early trials showed marked gastrointestinal and renal toxicities, treatment-related morbidity has been significantly alleviated with modern antiemetic therapy and adequate pretreatment hydration. More recent clinical studies of cisplatin have shown a broad range of activity and provide a better understanding of the drug's pharmacology, mechanism of action, and toxicity. Variations in the dosage and mode of administration as well as development of cisplatin analogues are being currently studied.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Animals
-
Cisplatin / adverse effects
-
Cisplatin / analogs & derivatives
-
Cisplatin / metabolism
-
Cisplatin / therapeutic use*
-
Drug Hypersensitivity / etiology
-
Female
-
Gastrointestinal Diseases / chemically induced
-
Gastrointestinal Neoplasms / drug therapy
-
Head and Neck Neoplasms / drug therapy
-
Hematologic Diseases / chemically induced
-
Humans
-
Kidney Diseases / chemically induced
-
Lung Neoplasms / drug therapy
-
Lymphoma / drug therapy
-
Male
-
Nervous System Diseases / chemically induced
-
Ovarian Neoplasms / drug therapy
-
Raynaud Disease / chemically induced
-
Reproduction / drug effects
-
Sarcoma / drug therapy
-
Testicular Neoplasms / drug therapy
-
Urogenital Neoplasms / drug therapy